The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Day One Biopharmaceuticals Inc’s stock clocked out at $16.64, up 8.19% from its previous closing price of $15.38. In other words, the price has increased by $8.19 from its previous closing price. On the day, 6.65 million shares were traded. DAWN stock price reached its highest trading level at $17.35 during the session, while it also had its lowest trading level at $15.11.
Ratios:
To gain a deeper understanding of DAWN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.72 and its Current Ratio is at 12.72. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on April 25, 2023, Downgraded its rating to Underperform and sets its target price to $9 from $34 previously.
On February 08, 2023, CapitalOne started tracking the stock assigning a Overweight rating and target price of $40.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 18 ’24 when Blackman Samuel C. sold 10,000 shares for $16.02 per share. The transaction valued at 160,163 led to the insider holds 1,174,662 shares of the business.
Blackman Samuel C. sold 10,000 shares of DAWN for $160,055 on Mar 25 ’24. The HEAD OF R&D now owns 1,184,662 shares after completing the transaction at $16.01 per share. On Mar 11 ’24, another insider, Blackman Samuel C., who serves as the HEAD OF R&D of the company, sold 30,000 shares for $15.24 each. As a result, the insider received 457,314 and left with 1,194,662 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DAWN now has a Market Capitalization of 1453956608 and an Enterprise Value of 978040064.
Stock Price History:
Over the past 52 weeks, DAWN has reached a high of $17.85, while it has fallen to a 52-week low of $9.67. The 50-Day Moving Average of the stock is 9.43%, while the 200-Day Moving Average is calculated to be 23.27%.
Shares Statistics:
It appears that DAWN traded 692.41K shares on average per day over the past three months and 1466770 shares per day over the past ten days. A total of 87.23M shares are outstanding, with a floating share count of 58.94M. Insiders hold about 32.55% of the company’s shares, while institutions hold 76.22% stake in the company. Shares short for DAWN as of 1711584000 were 8984718 with a Short Ratio of 12.98, compared to 1709164800 on 9703479. Therefore, it implies a Short% of Shares Outstanding of 8984718 and a Short% of Float of 12.83.
